employee
Simferopol, Russian Federation
The work studied the effectiveness of preventive measures for osteoporosis in adults, since most modern methods of its prevention do not always give a positive result than expected. Taking into account the long asymptomatic course of osteoporosis, in fact, secondary prevention of recurrent complications is carried out. At the same time, the main attention is paid to the consumption of calcium, as the main mineral for strengthening bone density, however, according to statistics, this does not lead to a decrease in the incidence of osteoporosis. Therefore, to assess the effectiveness of preventive measures, a literary review was carried out, both fatherland and foreign scientific sources, on the state of bone tissue for the entire period of life. The aim of our work is to identify periods of primary disorders of bone synthesis and its causes and, consequently, ways of preserving and restoring bone tissue throughout life. It was found, analyzing these sources on the state of bone tissue in childhood and adulthood, taking into account different geographical locations, that the quality of the structure of bone tissue, in the first place, depends on the quality of food and, first of all, on its mineral composition and vitamins. But, at present, taking into account factors that worsen both the external environment and food, bone mineralization is deteriorating, which requires constant replenishment of minerals, calcium preparations and natural vitamins. Particularly noteworthy is the fact that, as noted in all sources, bone formation disorders begin from childhood, therefore, maintaining normal bone mineralization in this period contributes to the formation of its strength for the rest of life, which forms the basis for the prevention of osteoporosis in adults. Moderate physical activity also plays an important role.
osteoporosis, bone, calcium, vitamins, trace elements, antioxidant system
1. Dedov I. I., Mel'nichenko G. A., Belaya Zh. E., Rozhinskaya L. Ya.: Osteoporoz - ot redkogo simptoma endokrinnyh bolezney do bezmolvnoy epidemii 20-21 veka. Problemy Endokrinologii. Moskva. 2011;57(4):35-45.
2. Novikova V. A., Autleva F. R., Hoseva E. N. Sovremennye vozmozhnosti lecheniya i profilaktiki osteoporoza u zhenschin v postmenopauze. Ginekolo- giya. Moskva. 2012;1(14):4-7.
3. Mazurov V. I., Sergeeva A. A., Trofimov E. A. Rol' preparatov kal'ciya v kompleksnom lechenii postmenopauzal'nogo osteoporoza. Medicinskiy Sovet. 2016;(5):114-119 doihttps://doi.org/10.21518/2079- 701X-2016-05-114-119.
4. Chernova T. O., Dashchyan K. A., Sazonova N. I., Mylov N. M. Rekomendacii Mezhdunarodnogo obschestva klinicheskoy densitometrii i rekomenduemoe primenenie v klinicheskoy i diagnosticheskoy praktike. Medicinskaya vizualizaciya. FGU Endokrinologicheskiy nauchnyy centr RAMN. Moskva. 2007;3:0-93. hiv]. Dostupno po: https://endocrincentr/ru//. Ssyl- ka aktivna na 12.12.16.
5. Ershova O. B., Belova K. Yu., Belov M. V., Ganert O. A., Gladkova E. N., Hodyrev V. N. Epidemiologiya perelomov proksimal'nogo otdela bedrennoy kosti u gorodskogo naseleniya Rossiyskoy Federacii: rezul'taty mnogocentrovogo issledovaniya. Forum osteoporoza, 23-25 sentyabrya. Materialy nauchno-prakticheskoy konferencii «Osteoporoz - vazhneyshaya mul'tidisciplinarnaya problema zdravoohraneniya XXI veka». Sankt-Peterburg. 2012;1:23-27.
6. Belaya Zh. E., Rozhinskaya L. Ya. Vitamin D v terapii osteoporoza: ego rol' v kombinacii s preparatami dlya lecheniya osteoporoza, vneskeletnye effekty. Effektivnaya Farmakoterapiya. Moskva. 2013;2:14-29.
7. Plescheva A. V., Pigarova E. A., Dzeranova L. K. Vitamin D i metabolizm: fakty, mify i pred- ubezhdeniya. Ozhirenie i metabolizm. Moskva. 2012;2:33-42.
8. Alekseeva L. I., Baranova I. A., Belova K. Yu., Ershova O. B., Zazerskaya I.E.: Klinicheskie rekomendacii po profilaktike i vedeniyu bol'nyh s osteoporozom. Sankt - Peterburg; Litera. 2012;2:23-2.
9. Nikitinskaya O. A., Toropcova N. V. Ocenka riska perelomov s ispol'zovaniem modeli FRAX® (retrospektivnoe desyatiletnee issledovanie) Al'manah klinicheskoy mediciny. Moskva. 2014;43:50-55.
10. Merkulov V. N., Mininkov D. S., Morozov A. K.: Problemy osteoporoza, osteopenii v detskoy travmatologii. Vestnik travmatologii i ortopedii im. N. N. Priorova. Moskva. 2008;2:24-28.
11. Rekomendacii rabochey gruppy VOZ po ob- sledovaniyu i lecheniyu bol'nyh s osteoporozom. Osteoporoz i osteopatii. Medicinskiy nauchno - prakticheskiy zhurnal. Moskva. 2016;4:2-7.
12. Kols E. K. Pravda ob osteoporoze [arhiv]. Dostupno po: http://www.36-6c.com//. Ssylka aktivna na 03.10.16.
13. Ray D. Strand. What our doctors do not know about nutritional medicine. New York: Thomas Nelson. 2008;79-82.
14. Grigor'eva N. V. Kal'ciy i formirovanie pika kostnoy massy u detey i podrostkov. Dityachiy likar. Harkiv. 2018;2( 9):54-63.
15. Sveshkov A. A., Hvostova S. A. Novye nauchnye izyskaniya i sposoby lecheniya. Mezhdunarodnyy zhurnal prikladnyh i fundamental'nyh issledovaniy. Moskva. 2016;7(1):54-68.
16. Vol'fgang Hegler, Klaus Kapelari Problemy osteoporoza. Mezhdunarodnyy endokrinologicheskiy zhurnal. Har'kov. 2014;7(63):43-58.
17. Camacho P. M., Petak S. M., Binkley N, Clarke B. L., Harris S. T., Hurley D. L., Kleerekoper M, Lewiecki E. M., Miller P. D., Narula H. S., Pessah- Pollack R, Tangpricha V,Wimalawansa SJ, Watts NB: American association of clinical endocrinologists and American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis 2016. Endocrinolgical Practical. 2016;Sep2;22(Suppl. 4):1-42.
18. Kanis J., McCloskey E., Johansson H., Cooper C., Rizzoli R. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis International. 2013;24(1):23-57. doihttps://doi.org/10.1007/s00198-012-2074-y.
19. Silverman S., Chines A., Kendler D. Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5- year, randomized, placebo-controlled study. Osteoporosis International. 2011;23(1):351-363. doihttps://doi.org/10.1007/s00198-011-1691-1.
20. Palacios S., Silverman S., de Villiers T. A. 7-year randomized, placebocontrolled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis. Menopause. 2015;22(8):806-813. doi:10.1097/ gme.0000000000000419.
21. Christiansen C., Chesnut C., Adachi J. Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis. BMC Musculoskeletal Disorders. 2010;11(1):30. doihttps://doi.org/10.1186/1471- 2474-11- 130.
22. Villiers T., Chines A., Palacios S. Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled phase 3 trial. Osteoporosis International. 2010;22(2):567-576. doihttps://doi.org/10.1007/s00198- 010-1302-6.
23. Gorshkova V. V., Kovaleva A. A. Vzaimosvyaz' magniya i kal'ciya v usloviyah stressa. GBOU VPO Orenburgskiy gosudarstvennyy medicinskiy universitet Ministerstva zdravoohraneniya RF. Studencheskiy nauchnyy forum 2016. [arhiv]. Dostupno po: https://scienceforum.ru/2016/article/2016023551//. Ssylka aktivna na 10.09.16.
